PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Status:
Recruiting
Trial end date:
2029-03-31
Target enrollment:
Participant gender:
Summary
Cancers of the pancreas, bile ducts, stomach and ovaries are dismal diseases with most
patients being diagnosed in advanced stages leading to a bad prognosis. These cancers can be
difficult to diagnose and sometimes impossible to differentiate from underlying benign
conditions. Establishing the correct diagnosis of primary cancer lesions and possible spread
to other organs in time is pivotal for choosing the right therapy. Routinely applied staging
procedures are however not always reliable. The main aim in this study is to evaluate the
diagnostic accuracy of PET/CT with a novel radiotracer, FAPI, in the primary diagnosis of
cancers in the pancreas, stomach and bile ducts as well as in patients with primary and
recurrent epithelial ovarian cancer (EOC).